These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 31468386

  • 1. Taurine Chloramine Inhibits Osteoclastic Differentiation and Osteoclast Marker Expression in RAW 264.7 Cells.
    Kang IS, Kim C.
    Adv Exp Med Biol; 2019; 1155():61-70. PubMed ID: 31468386
    [Abstract] [Full Text] [Related]

  • 2. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
    Cong F, Liu J, Wang C, Yuan Z, Bi L, Liang J, Su K, Qiu Y, Song T, Fan J, Chao G.
    Biomed Pharmacother; 2017 Aug; 92():927-934. PubMed ID: 28605877
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N, Kondo Y, Odkhuu E, Ulziisaikhan J, Ukaji T, Yokochi T, Umezawa K.
    Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
    [Abstract] [Full Text] [Related]

  • 4. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
    Kang MR, Jo SA, Yoon YD, Park KH, Oh SJ, Yun J, Lee CW, Nam KH, Kim Y, Han SB, Yu J, Rho J, Kang JS.
    Mar Drugs; 2014 Nov 24; 12(11):5643-56. PubMed ID: 25421321
    [Abstract] [Full Text] [Related]

  • 5. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH, Darvin P, Kang DY, Sp N, Byun HJ, Lee CH, Lee HK, Yang YM.
    PLoS One; 2016 Nov 24; 11(7):e0159891. PubMed ID: 27447722
    [Abstract] [Full Text] [Related]

  • 6. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.
    J Cell Physiol; 2009 Dec 24; 221(3):618-28. PubMed ID: 19653230
    [Abstract] [Full Text] [Related]

  • 7. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
    Ma Z, Yu R, Zhao J, Sun L, Jian L, Li C, Liu X.
    Inflamm Res; 2019 Feb 24; 68(2):157-166. PubMed ID: 30604211
    [Abstract] [Full Text] [Related]

  • 8. The effects of Lycii Radicis Cortex on RANKL-induced osteoclast differentiation and activation in RAW 264.7 cells.
    Kim JH, Kim EY, Lee B, Min JH, Song DU, Lim JM, Eom JW, Yeom M, Jung HS, Sohn Y.
    Int J Mol Med; 2016 Mar 24; 37(3):649-58. PubMed ID: 26848104
    [Abstract] [Full Text] [Related]

  • 9. Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathway.
    Doss HM, Samarpita S, Ganesan R, Rasool M.
    Life Sci; 2018 Aug 15; 207():284-295. PubMed ID: 29908722
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W, Dou H, Liu X, Sun L, Hou Y.
    Clin Exp Pharmacol Physiol; 2012 Oct 15; 39(10):886-93. PubMed ID: 23013134
    [Abstract] [Full Text] [Related]

  • 12. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
    Shim KS, Ma CJ, Kim DS, Ma JY.
    J Med Food; 2011 Nov 15; 14(11):1439-47. PubMed ID: 21883017
    [Abstract] [Full Text] [Related]

  • 13. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway.
    Baek JM, Park SH, Cheon YH, Ahn SJ, Lee MS, Oh J, Kim JY.
    Biochem Biophys Res Commun; 2015 May 29; 461(2):334-41. PubMed ID: 25887803
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S, Lee H, Yang Y, Jeong W.
    Free Radic Biol Med; 2013 Dec 29; 65():789-799. PubMed ID: 23954472
    [Abstract] [Full Text] [Related]

  • 16. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
    Nepal M, Choi HJ, Choi BY, Yang MS, Chae JI, Li L, Soh Y.
    Eur J Pharmacol; 2013 Sep 05; 715(1-3):96-104. PubMed ID: 23791609
    [Abstract] [Full Text] [Related]

  • 17. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
    Moon HJ, Ko WK, Jung MS, Kim JH, Lee WJ, Park KS, Heo JK, Bang JB, Kwon IK.
    J Food Sci; 2013 May 05; 78(5):H785-891. PubMed ID: 23582186
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Taurine chloramine inhibits osteoclastogenesis and splenic lymphocyte proliferation in mice with collagen-induced arthritis.
    Wang Y, Cha YN, Kim KS, Kim C.
    Eur J Pharmacol; 2011 Oct 01; 668(1-2):325-30. PubMed ID: 21816143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.